Related Experiment Video
Updated: Jun 22, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Frequent loss of SMAD4/DPC4 protein in colorectal cancers
R Salovaara1, S Roth, A Loukola
1Department of Medical Genetics, Haartman Institute, PO Box 63, FIN-00014 University of Helsinki, Finland.
Background And Aims:
Loss of DNA sequences from chromosome 18q21 is a major genetic change in colorectal tumorigenesis. Multiple genes have been identified in this area. One of these, DPC4 (deleted in pancreatic cancer 4, also known as SMAD4), is mutated in a minor subset of colorectal carcinomas as well as in germlines of humans predisposed to colon tumours.
Patients And Methods:
The involvement of SMAD4 in sporadic colorectal neoplasia was evaluated by immunohistochemistry in 53 unselected cases and 27 cases displaying microsatellite instability.
Results:
SMAD4 expression was absent in 20 of 53 (38%) unselected colorectal carcinomas, and reduced in another 15 (28%) cases. However, 26 of 27 cancers displaying microsatellite instability and TGF-betaIIR mutations were positive for SMAD4 immunostaining.
Conclusions:
Loss of SMAD4 expression may play a more prominent role in colon cancer than anticipated based on genetic evidence, but not in mutator phenotype tumours.
Insights
Loss of SMAD4 expression is frequent in sporadic colon cancer, suggesting a significant role in tumorigenesis. However, SMAD4 is typically retained in microsatellite instability-driven tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Chromosome 18q21 deletions are key in colorectal cancer.
- SMAD4 (DPC4) is a gene in this region, implicated in some colorectal carcinomas and hereditary colon cancer syndromes.
Purpose of the Study:
- To investigate the role of SMAD4 in sporadic colorectal neoplasia.
- To assess SMAD4 expression in colorectal tumors with and without microsatellite instability.
Main Methods:
- Immunohistochemistry was used to evaluate SMAD4 expression.
- The study included 53 unselected colorectal carcinomas and 27 cases with microsatellite instability.
Main Results:
- SMAD4 expression was lost or reduced in 66% of unselected colorectal carcinomas (38% absent, 28% reduced).
- In contrast, 96% of microsatellite instability-high tumors with TGF-betaIIR mutations retained SMAD4 expression.
Conclusions:
- Loss of SMAD4 expression appears to be a significant event in a substantial proportion of sporadic colorectal cancers.
- SMAD4 is generally preserved in colorectal cancers with a mutator phenotype, indicating distinct pathways.
Related Concept Videos
Pleiotropy
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

